Esperion Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Esperion Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Esperion Therapeutics Inc.
Rating: 1.75966675
Author: Trendlyne DVM scores

about

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

3.14 -0.03 (-0.95%)

355.07% Gain from 52W Low

4.3M

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

13.2 / 100

Technically Neutral

57.2 / 100

1Yr Price target upside is 107%

8 analysts

Esperion Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Esperion Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the bus...

355.07% Gain from 52W Low

SWOT Analysis

Esperion Therapeutics Inc Live Price Chart